reglab/housing_qa huggingface dataset:
CA Health & Safety Code § 121281 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 13 - Acquired Immune Deficiency Syndrome (AIDS) Immunization|Section 121281.

121281.  In order to assist pharmacists and pharmacy personnel in the education of consumers who are at risk of bloodborne infections regarding methods and opportunities for improving and protecting their health, and thereby protect the public health, the Office of AIDS shall develop and maintain all of the following information, on its Internet Web site, and the California State Board of Pharmacy shall also post, or maintain a link to, the information on its Internet Web site:(a) How consumers can access testing and treatment for HIV and viral hepatitis.(b) How consumers can safely dispose of syringes and hypodermic needles or other sharps waste.(c) How consumers can access drug treatment.(Added by Stats. 2011, Ch. 738, Sec. 12. (SB 41) Effective January 1, 2012.)
CA Health & Safety Code § 121287 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 13.6 - Public Health Demonstration Projects|Section 121287.

121287.  (a) There are hereby established public health demonstration projects to allow for innovative, evidence-based approaches to provide outreach, HIV and hepatitis C screenings, and linkage to, and retention in, quality health care for the most vulnerable and underserved individuals with a high risk for HIV infection.(b) The demonstration projects may operate for a period of up to two years. The department shall implement up to four demonstration projects. The demonstration projects shall be designed to be capable of replication and expansion on a statewide basis.(c) After conclusion of the demonstration projects, the department shall review the effectiveness of each demonstration project and make a determination of whether the demonstration project model can be implemented on a statewide basis.(Added by Stats. 2014, Ch. 40, Sec. 2. (SB 870) Effective June 20, 2014.)
CA Health & Safety Code § 121288 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 13.6 - Public Health Demonstration Projects|Section 121288.

121288.  Upon an appropriation for this purpose in the annual Budget Act, the department shall award funding, on a competitive basis, to a community-based organization or local health jurisdiction to operate a demonstration project pursuant to this chapter. The department shall determine the funding levels of each demonstration project based on scope and geographic area. An applicant shall demonstrate each of the following qualifications:(a) Leadership on access to HIV care and testing issues and experience addressing the needs of highly marginalized populations in accessing medical and HIV care and support.(b) Experience with the target population or relationships with community-based organizations or nongovernmental organizations, or both, that demonstrate expertise, history, and credibility working successfully in engaging the target population.(c) Experience working with nontraditional collaborators who work within and beyond the field of HIV/AIDS education and outreach, including areas of reproductive health, housing, immigration, and mental health.(d) Strong relationships with community-based HIV health care providers that have the trust of the targeted populations.(e) Strong relationships with the state and local health departments.(f) Capacity to coordinate a communitywide planning phase involving multiple community collaborators.(g) Experience implementing evidence-based programs or generating innovative strategies, or both, with at least preliminary evidence of program effectiveness.(h) Administrative systems and accountability mechanisms for grant management.(i) Capacity to participate in evaluation activities.(j) Strong communication systems that are in place to participate in public relations activities.(Added by Stats. 2014, Ch. 40, Sec. 2. (SB 870) Effective June 20, 2014.)
CA Health & Safety Code § 121289 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 13.6 - Public Health Demonstration Projects|Section 121289.

121289.  Each demonstration project shall prepare and disseminate information regarding best practices for, and the lessons learned regarding, providing outreach and education to the most vulnerable and underserved individuals with a high risk for HIV infection for use by providers, the Office of AIDS, State Department of Public Health, federal departments and agencies, including the Department of Health and Human Services, and other national HIV/AIDS groups.(Added by Stats. 2014, Ch. 40, Sec. 2. (SB 870) Effective June 20, 2014.)
CA Health & Safety Code § 121290 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 13.7 - Statewide African-American Initiative|Section 121290.

121290.  (a) There is hereby established the Statewide African-American Initiative to address the disproportionate impact of HIV/AIDS on the health of African-Americans by coordinating prevention and service networks around the state and increasing the capacity of core service providers. For purposes of this chapter, “initiative” means the Statewide African-American Initiative.(b) The initiative shall have an executive director who shall coordinate the initiative and report to the Office of AIDS through the Statewide African-American HIV/AIDS Steering Committee formally established pursuant to Section 121290.8.(c) The initiative shall be implemented in the following five designated regions:(1) Alameda/San Francisco.(2) Los Angeles.(3) Sacramento/Central Valley.(4) San Bernardino/Riverside.(5) San Diego.(d) (1) The Office of AIDS shall provide initial administrative support for the core functions of the initiative.(2) Until January 1, 2008, the initiative shall be housed at the Office of AIDS. By January 1, 2008, the initiative shall establish itself as an independent nonprofit organization for purposes of Section 501(c)(3) of the Internal Revenue Code.(Added by Stats. 2005, Ch. 403, Sec. 1. Effective January 1, 2006.)
CA Health & Safety Code § 121290.1 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 13.7 - Statewide African-American Initiative|Section 121290.1.

121290.1.  The initiative shall sponsor and conduct an annual Summit on African-Americans and HIV. The summit shall be funded solely by private funds. The summit shall do all of the following:(a) Provide a report on the progress of the initiative.(b) Offer technical assistance workshops.(c) Provide an overview of local, regional, and national efforts concerning health disparities relating to African-Americans and HIV.(Added by Stats. 2005, Ch. 403, Sec. 1. Effective January 1, 2006.)
CA Health & Safety Code § 121290.2 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 13.7 - Statewide African-American Initiative|Section 121290.2.

121290.2.  The initiative shall have all of the following responsibilities:(a) To design and conduct a series of complementary projects to implement policy and planning to address the disproportionate impact of HIV/AIDS on the African-American community, focusing on all of the following categories:(1) Research.(2) Policy and advocacy.(3) Workforce development.(4) Organizational capacity.(5) Prevention and treatment information and resources.(b) To provide integrated leadership in developing, implementing, evaluating, and sustaining HIV-related services and programmatic partnerships between research institutions, community-based organizations, the business community, and public sector agencies.(c) To improve the efficacy of local service providers through the central coordination of service availability, data, and funding sources through the development of a central coordinating body.(Added by Stats. 2005, Ch. 403, Sec. 1. Effective January 1, 2006.)
CA Health & Safety Code § 121290.4 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 13.7 - Statewide African-American Initiative|Section 121290.4.

121290.4.  The initiative shall employ all of the following strategies to achieve its objectives:(a) Serve as a community resource for technical assistance and training in the communication and dissemination of information, and for the synthesis, interpretation, and dissemination of HIV/AIDS data and public health information.(b) Assemble a network of health experts, HIV/AIDS service providers, community-based organizations, and relevant public and private sector stakeholders who will be accessible through the regional centers, to support the capacity building of community-based programs to eliminate HIV-related health disparities for African-Americans.(c) Establish the administrative, educational, and communication infrastructure, including personnel, facilities, and technology, to support the activities of the initiative’s provider network.(d) Assess the availability and allocation of scientific, governmental, and private sector resources to reduce the impact of HIV/AIDS on African-Americans.(e) Evaluate community-focused interventions and demonstration projects to eliminate disparities in the evaluation and treatment of HIV/AIDS, based on information from the work of the initiative and local and regional resources.(f) Coordinate and disseminate data, including epidemiology, outcome assessment, and informatics, to provider networks addressing health disparities regarding HIV/AIDS.(g) Facilitate the development of lasting academic and community partnerships that promote healthy lifestyles, prevent disease, and reduce risk factors for HIV/AIDS.(h) Increase ongoing access to culturally appropriate health care for African-Americans living with HIV/AIDS.(Added by Stats. 2005, Ch. 403, Sec. 1. Effective January 1, 2006.)
CA Health & Safety Code § 121290.5 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 13.7 - Statewide African-American Initiative|Section 121290.5.

121290.5.  (a) The initiative shall establish a central coordinating body to provide administrative, technical, educational, and health information dissemination services to the initiative’s network of community-based organizations.(b) The duties of the central coordinating body shall include, but not be limited to, all of the following:(1) Helping to provide program administration services, project management, fiscal support, resource allocation, and program evaluation to the initiative.(2) Assisting in the collection, management, and analysis of primary and secondary data, and providing technical support and training.(3) Aiding in the synthesis, interpretation, and dissemination of information on HIV and African-Americans.(c) The objectives of the central coordinating body shall include, but not be limited to, both of the following:(1) To achieve economies of scale in effort, expertise, and equipment, and thereby build the capacity of the provider network and the Office of AIDS to develop, implement, and evaluate community programs to address HIV/AIDS among African-Americans.(2) To pool services, expertise, equipment, and facilities to support several interrelated projects and collaborating organizations, thereby leveraging greater resources than those that would be provided separately to each project and without formal interactions among the Office of AIDS, community-based organizations, and public sector agencies.(Added by Stats. 2005, Ch. 403, Sec. 1. Effective January 1, 2006.)
CA Health & Safety Code § 121290.7 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 13.7 - Statewide African-American Initiative|Section 121290.7.

121290.7.  The Office of AIDS shall appoint an internal advisory committee composed of the office’s African-American HIV specialist, a section head from the office, and a designee to supervise the day-to-day activities of the initiative.(Added by Stats. 2005, Ch. 403, Sec. 1. Effective January 1, 2006.)
CA Health & Safety Code § 121290.8 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 13.7 - Statewide African-American Initiative|Section 121290.8.

121290.8.  There is hereby established the Statewide African-American HIV/AIDS Steering Committee. The committee shall be appointed by the Office of AIDS and shall initially consist of the current membership of the informally established Statewide African-American HIV/AIDS Steering Committee, which consists of leadership from service providers, researchers, educators, community-based organizations, and public sector agencies.(Added by Stats. 2005, Ch. 403, Sec. 1. Effective January 1, 2006.)
CA Health & Safety Code § 121290.9 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 13.7 - Statewide African-American Initiative|Section 121290.9.

121290.9.  The requirements of this chapter shall be implemented only after the Department of Finance makes a determination that nonstate funds in an amount sufficient to fully support the activities of the initiative have been deposited with the state. Thereafter, the requirements of this chapter shall be implemented only to the extent that nonstate funds are received for the purposes of this chapter.(Added by Stats. 2005, Ch. 403, Sec. 1. Effective January 1, 2006.)
CA Health & Safety Code § 121295 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 13.8 - HIV and Aging Demonstration Projects|Section 121295.

121295.  (a) The State Department of Public Health, in consultation with the California Department of Aging, shall establish a program for demonstration projects to allow for innovative, evidence-informed approaches to improve the health and well-being of older people living with HIV.(b) The demonstration projects shall address the multidisciplinary clinical and nonclinical needs of older people living with HIV.(c) The demonstration projects shall be responsive to the unique needs of older people living with HIV in the specific geographic area.(d) The demonstration projects shall operate for a period of up to three years. The department shall implement up to five demonstration projects.(e) The demonstration projects shall include an evaluation component and a plan for disseminating lessons learned in order to develop new programs and strengthen existing programs.(f) (1) The department shall establish a process to request applications, and award funding on a competitive basis, for an eligible entity to operate a demonstration project pursuant to this chapter.(2) An application to operate a demonstration project under this chapter shall be evaluated based on need in the geographic area, populations served, competency of the entity applying, and program design.(g) The department shall determine the funding levels of each demonstration project based on the scope of the project and need in the specific geographic area.(h) Any entity in any county shall be eligible to operate a demonstration project pursuant to this chapter if it meets both of the following requirements:(1) Demonstrates experience and expertise in providing culturally appropriate services to the most vulnerable and underserved older people living with HIV, including, but not limited to, older people living with HIV who are Black, Indigenous, and people of color.(2) Demonstrates the capacity to ensure that the multidisciplinary clinical and nonclinical needs of older people living with HIV are assessed and addressed. Services may be colocated or coordinated across different locations, including through referrals or partnerships with other entities.(Added by Stats. 2021, Ch. 143, Sec. 25. (AB 133) Effective July 27, 2021.)
CA Health & Safety Code § 121305 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 14 - Acquired Immune Deficiency Syndrome (AIDS) Clinical Trial Grant Award for the Prevention of Maternal Transmission of Human Immunodeficiency Virus (HIV) Infection|Section 121305.

121305.  For the purposes of this chapter, the following definitions apply:(a)  “AIDS” means acquired immune deficiency syndrome. (b)  “An HIV-positive individual” means an individual who is infected with the AIDS virus. (c)  “Committee” means the AIDS Vaccine Research and Development Advisory Committee. (d)  “Grant award” means an AIDS Vaccine Clinical Trial Grant Award for the Prevention of Maternal Transmission of HIV Infection. (e)  “AIDS vaccine,” for the purposes of this chapter, means a vaccine that has been developed by a manufacturer and is being tested and administered for the purposes of determining whether immunization of HIV-infected pregnant women will protect against maternal transmission of the AIDS virus. Clinical trials must be conducted under an investigational new drug (IND) application on file with the federal Food and Drug Administration (FDA). (f)  “Research subject” means a person who is administered an AIDS vaccine, or a fetus of a woman administered an AIDS vaccine, or a child born to a woman administered an AIDS vaccine during pregnancy. (g)  “Researcher” means a person employed by or affiliated with a manufacturer or a research institution, who participates in the development or testing or administration of an AIDS vaccine, or who is involved in the diagnosis and treatment of a research subject. (Amended by Stats. 1997, Ch. 294, Sec. 23. Effective August 18, 1997.)
CA Health & Safety Code § 121310 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 14 - Acquired Immune Deficiency Syndrome (AIDS) Clinical Trial Grant Award for the Prevention of Maternal Transmission of Human Immunodeficiency Virus (HIV) Infection|Section 121310.

121310.  A manufacturer, research institution, or researcher shall, prior to the administration of an AIDS vaccine to a research subject, obtain that woman’s informed consent, that shall comply with all applicable statutes and regulations.(a)  The informed consent shall contain a statement that significant new findings developed during the course of the research that may relate to the subject’s willingness to continue participation will be provided to the subject. (b)  A copy of the informed consent shall be maintained with the woman’s medical records. (Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)
CA Health & Safety Code § 121315 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 14 - Acquired Immune Deficiency Syndrome (AIDS) Clinical Trial Grant Award for the Prevention of Maternal Transmission of Human Immunodeficiency Virus (HIV) Infection|Section 121315.

121315.  (a)  A manufacturer, research institution, or researcher shall not be strictly liable for personal injury or wrongful death resulting from the administration of any AIDS vaccine to a research subject participating in the clinical trials described in this chapter. (b)  It is the intent of the Legislature in enacting this section to confer upon manufacturers, research institutions, and researchers participating in the clinical trials described in this chapter an immunity from liability to the same extent as conferred upon specified pharmaceutical manufacturers under Brown v. Superior Court, 44 Cal. 3d 1049. (c)  No immunity shall be conferred to the extent that the injury or death was caused by the negligence, gross negligence, or reckless, willful, or wanton misconduct of the manufacturer, research institution, or researcher or the manufacturer, research institution, or the researcher has failed to comply with Section 121310. (d)  The immunity provided by this section shall not apply to a manufacturer, research institution, or researcher who intentionally provided false information to the FDA in connection with an IND application. (e)  Notwithstanding the immunity provided by this section, nothing in this section shall be construed to affect the inapplicability or applicability of the holding in Brown v. Superior Court, 44 Cal. 3d 1049 to other situations involving the same or similar conduct. (Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)
CA Health & Safety Code § 121320 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 14 - Acquired Immune Deficiency Syndrome (AIDS) Clinical Trial Grant Award for the Prevention of Maternal Transmission of Human Immunodeficiency Virus (HIV) Infection|Section 121320.

121320.  No person shall be denied the opportunity to be a research subject because of the inability to pay for medical treatment.(Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)
CA Health & Safety Code § 121330 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 14 - Acquired Immune Deficiency Syndrome (AIDS) Clinical Trial Grant Award for the Prevention of Maternal Transmission of Human Immunodeficiency Virus (HIV) Infection|Section 121330.

121330.  If a manufacturer that is a grant recipient sells, delivers, or distributes an AIDS vaccine that has received FDA approval for use by the general population and that was developed in whole or in part using a grant awarded pursuant to this chapter, the State of California shall be reimbursed for the grant as provided in this section.Until the total amount of the grant is repaid, repayments in the amount of one dollar ($1) per dose from the sale of the AIDS vaccine shall be deposited by the grant recipient into the General Fund. Upon payment in full of the grant amount into the General Fund, a royalty on the sale of the vaccine from the grant recipient shall be deposited into the General Fund. The percentage amount of the royalty shall be negotiated at the time of the grant award.(Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)
CA Health & Safety Code § 121335 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 14 - Acquired Immune Deficiency Syndrome (AIDS) Clinical Trial Grant Award for the Prevention of Maternal Transmission of Human Immunodeficiency Virus (HIV) Infection|Section 121335.

121335.  It is the intent of the Legislature for the department to make every effort possible to insure a comprehensive and diverse expert representation on the committee. It is the intent of the Legislature to ensure that expert members of the committee include, but are not limited to, ethnic minorities and women.(Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)